We validated the quantitative reverse transcription PCR (qRT-PCR) results by immunoprobing for BRCA2, XPD and APE1 proteins in the PBL of all 106 HNSCC patients and 122 controls recruited for this study. Here, BRCA2 is linked to head and neck squamous cell carcinoma.